A Japanese health ministry panel approved Wednesday the administration of U.S. biotechnology firm Moderna Inc.'s COVID-19 booster shots at least six months after an individual aged 18 or older has received their second dose.The third dose will use half the 0.5 milliliter amount used for each of the first two shots. Moderna's COVID-19 vaccine is the second to be approved for use as booster shots in Japan after Pfizer Inc. received the green light last month.Japan has set an eight-month interval "in principle" between second vaccination shots and a booster but has been working to bring forwar…READ FULL ARTICLE